Question 1

What is the new implant device for type 1 diabetes?

Accepted Answer

The new implant device developed by MIT contains insulin-producing islet cells that help regulate blood sugar levels from inside the body. It is designed to reduce or eliminate the need for daily insulin injections by providing a continuous, natural source of insulin.

Question 2

How does the implant protect insulin-producing cells from the immune system?

Accepted Answer

The device uses a protective encapsulation system that shields the islet cells from immune attack. This allows the cells to function without requiring immunosuppressive drugs, which are typically needed in traditional islet cell transplants.

Question 3

How long did the implant work in research studies?

Accepted Answer

In animal studies, the implant functioned for at least 90 days. During this time, the cells remained alive, produced insulin, and helped maintain stable blood sugar levels in mice and rats.

Question 4

Could this device cure type 1 diabetes?

Accepted Answer

The device has not yet cured type 1 diabetes, but it has shown promising results in controlling blood sugar levels. Researchers are working to improve the technology so it may eventually provide long-term or near-complete insulin independence.

Question 5

When will this diabetes implant be available for humans?

Accepted Answer

The implant is still in early research stages and has only been tested in animals. Human clinical trials are expected in the future, but it may take several years before the device becomes widely available.

Question 6

How is this different from traditional islet cell transplants?

Accepted Answer

Traditional islet transplants require lifelong immunosuppressive drugs to prevent rejection. This new device avoids that need by protecting the cells while also supplying oxygen, improving cell survival and safety.

Artificial Pancreas

Type 1 Diabetes Implant Device Could Replace Insulin Injections

The iLet Bionic Pancreas, No Need to Count Carbs

Type 1 Diabetes Technology Gets Patients Closer to Targets

Dual-Hormone Artificial Pancreas Improves Glucose Control in Diabetes

T1D Breakthroughs Hopeful in 2018

MiniMed 670G System Available Spring 2017

Artificial Pancreas Approved by FDA for Diabetes

Artificial Pancreas Shows Promise in Type 1 Diabetes

Diabetes Research